Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Morton

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 24, 2023
Trends in the Incidence of End-Stage Kidney Disease in Type 1 and Type 2 Diabetes in Australia, 2010-2019Jedidiah I Morton, Bendix Carstensen, Stephen P McDonald, et al.
Diabetologia|December 13, 2022
Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st centuryPeter A Lazzarini, Susanna M Cramb, Jonathan Golledge, et al.
Diabetes Research and Clinical Practice|February 10, 2024
The effect of frailty on post-discharge management and outcomes of acute glycaemic crises: Analysis of admissions for hypoglycaemia and hyperglycaemia in AustraliaJedidiah I Morton, Jenni Ilomäki, Stephen J Wood, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 2021
Changes in excess mortality among adults with diabetes-related end-stage kidney disease: a comparison between the USA and AustraliaJessica L Harding, Jedidiah I Morton, Jonathan E Shaw, et al.
Diabetologia|November 20, 2022
Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysisJedidiah I Morton, Clara Marquina, Jonathan E Shaw, et al.
Pharmacoeconomics|December 1, 2024
Immediate Versus 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease for Australians Aged 40 Years: A Health Economic AnalysisJedidiah I Morton, Danny Liew, Gerald F Watts, et al.
Pharmacoeconomics|March 22, 2023
Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022-2031Dina Abushanab, Clara Marquina, Jedidiah I Morton, et al.
Research in Social & Administrative Pharmacy : RSAP|March 18, 2025
Evaluating the implementation of a rapid access atrial fibrillation clinic utilising a pharmacist-physician model of careAdam C Livori, Rasantha Kuruppumullage, Mardi Simmons, et al.
Journal of Epidemiology and Community Health|April 26, 2022
Treatment gaps, 1-year readmission and mortality following myocardial infarction by diabetes status, sex and socioeconomic disadvantageJedidiah I Morton, Jenni Ilomäki, Stephen J Wood, et al.
European Journal of Preventive Cardiology|September 5, 2024
The Reduction of the Productivity Burden of Cardiovascular Disease by Improving the Risk Factor Control Among Australians with Type 2 Diabetes: A 10-Year Dynamic AnalysisDina Abushanab, Daoud Al-Badriyeh, Clara Marquina, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 24, 2023
Trends in the Incidence of End-Stage Kidney Disease in Type 1 and Type 2 Diabetes in Australia, 2010-2019Jedidiah I Morton, Bendix Carstensen, Stephen P McDonald, et al.
Diabetologia|December 13, 2022
Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st centuryPeter A Lazzarini, Susanna M Cramb, Jonathan Golledge, et al.
Diabetes Research and Clinical Practice|February 10, 2024
The effect of frailty on post-discharge management and outcomes of acute glycaemic crises: Analysis of admissions for hypoglycaemia and hyperglycaemia in AustraliaJedidiah I Morton, Jenni Ilomäki, Stephen J Wood, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 2021
Changes in excess mortality among adults with diabetes-related end-stage kidney disease: a comparison between the USA and AustraliaJessica L Harding, Jedidiah I Morton, Jonathan E Shaw, et al.
Diabetologia|November 20, 2022
Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysisJedidiah I Morton, Clara Marquina, Jonathan E Shaw, et al.
Pharmacoeconomics|December 1, 2024
Immediate Versus 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease for Australians Aged 40 Years: A Health Economic AnalysisJedidiah I Morton, Danny Liew, Gerald F Watts, et al.
Pharmacoeconomics|March 22, 2023
Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022-2031Dina Abushanab, Clara Marquina, Jedidiah I Morton, et al.
Research in Social & Administrative Pharmacy : RSAP|March 18, 2025
Evaluating the implementation of a rapid access atrial fibrillation clinic utilising a pharmacist-physician model of careAdam C Livori, Rasantha Kuruppumullage, Mardi Simmons, et al.
Journal of Epidemiology and Community Health|April 26, 2022
Treatment gaps, 1-year readmission and mortality following myocardial infarction by diabetes status, sex and socioeconomic disadvantageJedidiah I Morton, Jenni Ilomäki, Stephen J Wood, et al.
European Journal of Preventive Cardiology|September 5, 2024
The Reduction of the Productivity Burden of Cardiovascular Disease by Improving the Risk Factor Control Among Australians with Type 2 Diabetes: A 10-Year Dynamic AnalysisDina Abushanab, Daoud Al-Badriyeh, Clara Marquina, et al.
Pageof 14